139 related articles for article (PubMed ID: 37876208)
21. Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.
Cipriano C; Griffin AM; Ferguson PC; Wunder JS
Clin Orthop Relat Res; 2017 Mar; 475(3):830-838. PubMed ID: 27339121
[TBL] [Abstract][Full Text] [Related]
22. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence.
Martin RC; Edwards MJ; Cawte TG; Sewell CL; McMasters KM
Cancer; 2000 Mar; 88(6):1365-9. PubMed ID: 10717618
[TBL] [Abstract][Full Text] [Related]
23. Leiomyosarcoma of the inferior vena cava: three case reports and review of the literature.
Hilliard NJ; Heslin MJ; Castro CY
Ann Diagn Pathol; 2005 Oct; 9(5):259-66. PubMed ID: 16198953
[TBL] [Abstract][Full Text] [Related]
24. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
25. Twenty-five cases of adult prostate sarcoma treated at a high-volume institution from 1989 to 2009.
Wang X; Liu L; Tang H; Rao Z; Zhan W; Li X; Zeng H; Zhang P; Wei B; Lin T; Wei Q; Lu Y; Li X
Urology; 2013 Jul; 82(1):160-5. PubMed ID: 23601444
[TBL] [Abstract][Full Text] [Related]
26. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.
Kamitani R; Matsumoto K; Takeda T; Mizuno R; Oya M
BMC Cancer; 2022 Jan; 22(1):15. PubMed ID: 34980039
[TBL] [Abstract][Full Text] [Related]
27. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
29. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
Chou FF; Eng HL; Sheen-Chen SM
Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
[TBL] [Abstract][Full Text] [Related]
30. Outcomes and prognostic factors for a consecutive case series of 115 patients with somatic leiomyosarcoma.
Abraham JA; Weaver MJ; Hornick JL; Zurakowski D; Ready JE
J Bone Joint Surg Am; 2012 Apr; 94(8):736-44. PubMed ID: 22517390
[TBL] [Abstract][Full Text] [Related]
31. Oncological outcome of patients with deeply located soft tissue sarcoma of the pelvis: a follow up study at minimum 5 years after diagnosis.
Nakamura T; Abudu A; Murata H; Grimer RJ; Carter SR; Tillman RM; Jeys L
Eur J Surg Oncol; 2013 Sep; 39(9):1030-5. PubMed ID: 23347778
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors.
Aneiros-Fernandez J; Antonio Retamero J; Husein-Elahmed H; Ovalle F; Aneiros-Cachaza J
Eur J Dermatol; 2016; 26(1):9-12. PubMed ID: 26678649
[TBL] [Abstract][Full Text] [Related]
33. Results of aggressive treatment of gastric sarcoma.
Carson W; Karakousis C; Douglass H; Rao U; Palmer ML
Ann Surg Oncol; 1994 May; 1(3):244-51. PubMed ID: 7531105
[TBL] [Abstract][Full Text] [Related]
34. Tumor-associated mortality and prognostic factors in myxofibrosarcoma - A retrospective review of 109 patients.
Gilg MM; Sunitsch S; Leitner L; Bergovec M; Szkandera J; Leithner A; Liegl-Atzwanger B
Orthop Traumatol Surg Res; 2020 Oct; 106(6):1059-1065. PubMed ID: 32778437
[TBL] [Abstract][Full Text] [Related]
35. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous leiomyosarcoma: dermal and subcutaneous.
Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
[TBL] [Abstract][Full Text] [Related]
37. Leiomyosarcoma of the head and neck: A 17-year single institution experience and review of the National Cancer Data Base.
Workman AD; Farquhar DR; Brody RM; Parasher AK; Carey RM; Purkey MT; Nagda DA; Brooks JS; Hartner LP; Brant JA; Newman JG
Head Neck; 2018 Apr; 40(4):756-762. PubMed ID: 29286183
[TBL] [Abstract][Full Text] [Related]
38. Mohs micrographic surgery for the treatment of cutaneous leiomyosarcoma.
Starling J; Coldiron BM
J Am Acad Dermatol; 2011 Jun; 64(6):1119-22. PubMed ID: 21571171
[TBL] [Abstract][Full Text] [Related]
39. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Histopathologic Findings of Cutaneous Leiomyosarcoma: Correlation with Prognosis in 12 Patients.
Rodríguez-Lomba E; Molina-López I; Parra-Blanco V; Suárez-Fernández R; Pulido-Pérez A
Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):140-147. PubMed ID: 29100621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
